Page 116 - HIVMED_v21_i1.indb

Page 25 of 34 Guideline

References 28. Morgan N, Daniels W, Subramaney U. A prospective observational study of heroin
users in Johannesburg, South Africa: Assessing psychiatric comorbidities and
treatment outcomes. Compr Psychiatr. 2019 Oct;95:152137. https://doi.
1. Siegel R. Intoxication: The universal drive for mind-altering substances. Rochester: org/10.1016/j.scs.2019.101770
Park Street Press; 2005. 29. Global Commission on Drug Policy. Classification of psychoactive substances:
2. UNODC. World drug report 2019. Executive summary. Vienna: UNODC; 2019. When science was left behind. Geneva: Global Commission on Drug Policy, 2019;
p. 55.
3. Transform Drug Policy Foundation. Count the costs. 50 years of the war on drugs.
London: Transform Drug Policy Foundation, 2012; p. 1–16. 30. Van Amsterdam J, Nutt D, Phillips L, Van den Brink W. European rating of drug
4. Scheibe A, Shelly S, Versfeld A, Howell S, Marks M. Safe treatment and treatment harms. J Psychopharmacol [serial online]. 2015 Jun;29(6):655–660. Available
from: http://journals.sagepub.com/doi/10.1177/0269881115581980
of safety: Call for a harm-reduction approach to drug-use disorders in South
Africa. S Afr Health Rev. 2017;20:197–204. 31. Shelly S, Broughton I, Mcbide A, et al. Every single person looks at us bad. Cape
Town: South African Network of People Who Use Drugs, 2017; p. 1–43.
5. Harm Reduction International. The global state of harm reduction 2018. 6th ed.
London: Harm Reduction International; 2018. 32. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 Myths
about HIV/AIDS and people who use drugs. Lancet. 2010;376(9737):208–211.
6. Harm Reduction International. What is harm reduction? [homepage on the https://doi.org/10.1016/S0140-6736(10)61005-7
Internet]. [cited 2020 Mar 5]. Available from: https://www.hri.global/what-is-
harm-reduction 33. Buchanan J. Understanding problematic drug use: A medical matter or a social
7. Hawk M, Coulter RWS, Egan JE, et al. Harm reduction principles for healthcare issue? Br J Community Justice. 2006;4(2):47–61.
settings. Harm Reduct J [serial online]. 2017 Dec 24;14(1):70. Available from: 34. Ndimbii JN, Guise A, Ayon S, Kalama M, McLean S, Rhodes T. Implementing needle
http://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017- and syringe programmes in Kenya: Changes, opportunities and challenges in HIV
0196-4 prevention. Afr J Drug Alcohol Stud. 2015;14(2):95–103.
8. Zinberg N. Drug, set and setting: The basis for controlled intoxicant use. 35. Mauritian Ministry of Health and Quality of Life. Statistics on HIV/AIDS. Port Louis,
New Haven, CT: Yale University Press; 1984. Government of Mauritius; 2015.
9. World Health Organization. ICD-11 for mortality and morbidity statistics. Geneva: 36. Police Force. Arrest rates 2007–2012. Port Louis: Mauritian Ministry of Health and
WHO. Quality of Health; 2013.
10. Waldo Zuardi A, Alexandre S. Crippa J, et al. A critical review of the antipsychotic 37. Canadian Network on Hepatitis C Blueprint Writing Committee and Working
effects of cannabidiol: 30 years of a translational investigation. Curr Pharm Des Groups. Blueprint to inform hepatitis C elimination efforts in Canada. Montreal:
[serial online]. 2012 Sep 12;18(32):5131–5140. Available from: http://www. Canadian Network on Hepatitis C, 2019; p. 23.
eurekaselect.com/openurl/content.php?genre=article&issn=1381-6128&volume
=18&issue=32&spage=5131 38. Kelly JF, Saitz R, Wakeman S. Language, substance use disorders, and policy: The
need to reach consensus on an ‘Addiction-ary’. Alcohol Treat Q [serial online].
11. Brennan R, Wells JSG, Van Hout MC. The injecting use of image and performance- 2016 Jan 2;34(1):116–123. Available from: http://www.tandfonline.com/doi/full/
enhancing drugs (IPED) in the general population: A systematic review. Health Soc 10.1080/07347324.2016.1113103
Care Community. 2017;25(5):1459–1531. https://doi.org/10.1111/hsc.12326 39. Nyblade L, Stockton MA, Giger K, et al. Stigma in health facilities: Why it matters
12. Khine A, Mokwena K, Huma M, Fernandes L. Identifying the composition of street and how we can change it. BMC Med. 2019;17(1):1–15. https://doi.org/10.1186/
drug Nyaope using two different mass spectrometer methods. Afri J Drug Alcohol s12916-019-1256-2
Stud. 2015;14(1):49–56.
40. INPUD. Statement and position paper on language, inclusivity and discrimination
13. Dada S, Harker N, Jodilee B, et al. April 2019 | phase 44. Cape Town: SA Medical [homepage on the Internet]. London: International Network of People who Use
Research Council; 2019. Drugs, 2011; p. 1–6. Available from: http://www.inpud.net/INPUD_Statement_
14. Peltzer K, Phaswana-Mafuya N. Drug use among youth and adults in a population- Position_Paper_on_Language_Identity_Inclusivity_Discrimination_Nov2011.pdf
based survey in South Africa. S Afr J Psychiatr. 2018;24(1):1–6. https://doi. 41. ARASA. ‘Don’t treat us as outsiders’. Drug policy and the lived experiences of
org/10.4102/sajpsychiatry.v24i0.1139 people who use drugs in Southern Africa. Windhoek: AIDS and Rights Alliance for
15. Dada S, Harker-Burnhams N, Erasmus J, et al. SACENDU. Monitoring alcohol, southern Africa; 2019.
tobaccoe and other drug use trends (South Africa): July–December 2018. Vol. 42. Govender RD, Schlebusch L. A suicide risk screening scale for HIV-infected persons
Phase 45. Cape Town: Medical Research Council; 2018. in the immediate post-diagnosis period. South Afr J HIV Med [serial online]. 2013
16. Olashore AA, Ogunwobi O, Totego E, Opondo PR. Psychoactive substance use Jun 4;14(2):58–63. Available from: https://sajhivmed.org.za/index.php/hivmed/
among first-year students in a Botswana University: Pattern and demographic article/view/79
correlates. BMC Psychiatry. 2018;18(1):1–9. https://doi.org/10.1186/s12888-018- 43. Agerwala SM, McCance-Katz EF. Integrating Screening, Brief Intervention, and
1844-2 Referral to Treatment (SBIRT) into clinical practice settings: A brief review. J
17. UNODC. World drug report 2019 data [homepage on the Internet]. World drug Psychoactive Drugs [serial online]. 2012 Sep 1;44(4):307–317. Available from:
report 2019. Vienna; 2019 [cited 2019 Sep 03]. Available from: https://wdr.unodc. https://www.tandfonline.com/doi/full/10.1080/02791072.2012.720169
org/wdr2019/index.html 44. WHO. The ASSIST project – Alcohol, smoking and substance involvement
18. United Nations. Single convention on narcotic drugs [homepage on the Internet]. screening test [homepage on the Internet]. [cited 2019 Oct 15]. Available from:
Final act of the united nations conference for the adoption of a single convention https://www.who.int/substance_abuse/activities/assist/en/
on narcotic drugs. Vienna: United Nations, 1961; p. 44. Available from: https:// 45. Humeniuk R, Henry-Edwards S, Ali R, Poznyak V, Monteiro MG, World Health
www.unodc.org/pdf/convention_1961_en.pdf Organization. The ASSIST-linked brief intervention for hazardous and harmful
19. World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, substance use: A manual for use in primary care / prepared by R. HumeniukƯ
treatment and care for key populations. Geneva: World Health Organization; [et al.] [homepage on the Internet]. Geneva: World Health Organization, 2010;
2016. 40p. Available from: https://apps.who.int/iris/handle/10665/44321
20. Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: Review and 46. Van Der Westhuizen C, Myers B, Malan M, et al. Implementation of a screening,
update. Clin Infect Dis. 2009 Jan;48(1):72–82. https://doi.org/10.1086/594126 brief intervention and referral to treatment programme for risky substance use in
South African emergency centres: A mixed methods evaluation study. PLoS One.
21. Viviers PJ, Van Zyl-Smit RN. Chronic obstructive pulmonary disease – Diagnosis 2019;14(11):1–20. https://doi.org/10.1371/journal.pone.0224951
and classification of severity. S Afr Med J. 2015;105(9):786–788. https://doi.
org/10.7196/SAMJnew.8421 47. Beyer F, Lynch E, Kaner E. Brief interventions in primary care: An evidence
overview of practitioner and digital intervention programmes. Curr Addict
22. Burhan H, Young R, Byrne T, et al. Screening heroin smokers attending community Reports. 2018;5(2):265–273. https://doi.org/10.1007/s40429-018-0198-7
drug services for COPD. Chest. 2019;155(2):279–287. https://doi.org/10.1016/j.
chest.2018.08.1049 48. Malta M, Magnanini MMF, Strathdee SA, Bastos FI. Adherence to antiretroviral
therapy among HIV-infected drug users: A meta-analysis. AIDS Behav [serial
23. UNAIDS. Health, rights and drugs. Harm reduction, decriminalization and zero online]. 2010 Aug 20;14(4):731–747. Available from: http://link.springer.
discrimination for people who use drugs. Geneva: Joint United Nations com/10.1007/s10461-008-9489-7
Programme on HIV/AIDS; 2019.
24. Teodoro E, Boothe M, Baltazar C, et al. Urgent need for harm-reduction 49. Colfax G, Santos G-M, Chu P, et al. Amphetamine-group substances and HIV.
Lancet [serial online]. 2010 Aug;376(9739):458–474. Available from: https://
interventions in Mozambique: Results from the integrated bio-behavioral linkinghub.elsevier.com/retrieve/pii/S0140673610607532
survey among people who inject drugs. In: IAS 2015. Vancouver; 2015. p.
Presentation. 50. SAHMSA. Screening, Brief Intervention and Referral to Treatment (SBIRT) in
Behavioral healthcare. Rockville; Substance Abuse and Mental Health Services
25. University of California San Francisco, Anova Health Institute, National Institute Administration; 2011.
for Communicable Diseases. Brief report of the tipval study: An integrated bio-
behavioral surveillance survey among people who inject drugs. San Francisco, CA: 51. UNODC, WHO, UNAIDS. HIV prevention, treatment, care and support for people
University of California San Francisco; 2018. who use stimulant drugs. Vienna: United Nations Office on Drugs and Crime; 2019.
26. Scheibe A, Young K, Moses L, et al. Understanding hepatitis B, hepatitis C and HIV 52. UNODC, INPUD, UNAIDS, et al. Implementing comprehensive HIV and HCV
among people who inject drugs in South Africa: Findings from a three-city cross- programmes with people who inject drugs. Practical guidance for collaborative
sectional survey. Harm Reduct J. 2019;16(28):1–11. https://doi.org/10.1186/ inteventions. IDUIT. Vienna: United Nations Office on Drugs and Crime, 2017;
s12954-019-0298-2 p. 1–175.
27. Dannatt L, Cloete KJ, Kidd M, Weich L. Frequency and correlates of comorbid 53. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among
psychiatric illness in patients with heroin use disorder admitted to Stikland Opioid injecting drug users: a comprehensive review of the international evidence.
Detoxification Unit, South Africa. S Afr J Psychiatr. 2014;20(3):77. https://doi. Subst Use Misuse. 2006;41(6–7):777–813. https://doi.org/10.1080/10826080
org/10.4102/sajpsychiatry.v20i3.540 600669579
http://www.sajhivmed.org.za 108 Open Access